All In MedTech

FDA Clearance Tracker · P970051-S025

NUCLEUS 24 COCHLEAR IMPLANT SYSTEM WITH CONTOUR ADVANCE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 7, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 7, 2003

Approved

Time to decision

86 days

Received Aug 13, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P970051-S025
Device name
NUCLEUS 24 COCHLEAR IMPLANT SYSTEM WITH CONTOUR ADVANCE
Applicant location
Lone Tree, CO
Received
Aug 13, 2003
Decided
Nov 7, 2003
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P970051

Device type

Device class
Class III

Every decision under product code MCM

FDA's approval statement

As written in FDA's record.

APPROVAL OF A MARKETING NAME CHANGE FROM NUCLEUS 24 COCHLEAR IMPLANT SYSTEM WITH CONTOUR SOFTIP ELECTRODE TO NUCLEUS 24 CONTOUR ADVANCE.

Source documents

Other decisions for Cochlear Americas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.